Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis
Distant metastases from pancreatic cancer patients were previously reported by the authors to be dependent on the glucose-metabolizing enzyme phosphogluconate dehydrogenase (PGD). Here the authors report a novel metabolic adaptation that that stably activates PGD to reprogram metastatic chromatin.
Guardado en:
Autores principales: | Matthew E. Bechard, Rana Smalling, Akimasa Hayashi, Yi Zhong, Anna E. Word, Sydney L. Campbell, Amanda V. Tran, Vivian L. Weiss, Christine Iacobuzio-Donahue, Kathryn E. Wellen, Oliver G. McDonald |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4506861df93c451294cd63802d5a994b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FOXF2 reprograms breast cancer cells into bone metastasis seeds
por: Shuo Wang, et al.
Publicado: (2019) -
Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance
por: Zhiquan Wang, et al.
Publicado: (2021) -
Liquid condensation of reprogramming factor KLF4 with DNA provides a mechanism for chromatin organization
por: Rajesh Sharma, et al.
Publicado: (2021) -
Ordered chromatin changes and human X chromosome reactivation by cell fusion-mediated pluripotent reprogramming
por: Irene Cantone, et al.
Publicado: (2016) -
Transcriptional activation during cell reprogramming correlates with the formation of 3D open chromatin hubs
por: Marco Di Stefano, et al.
Publicado: (2020)